Long-Term Follow-Up after Allogeneic Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation

Volumn 6, Issue 4 A, 2000, Pages 428-433

  Isola, Luis ^a,b   Scigliano, Eileen ^a   Fruchtman, Steven ^a  

^a Division of Hematology   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Cytokine; Harvest; Mobilization; Stem cells; Transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; MALE; MIDDLE AGED; STEM CELL MOBILIZATION; TIME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034566477     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(00)70034-6     Document Type: Article

References (11)

1. Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood. 1995;85:1655-1658.
2. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood. 1995;85: 1659-1665.
3. Ringden O, Remberger M, Runde V, et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation. Blood. 1999;94:455-464.
4. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995;86:2842-2848.
5. Brown RA, Adkins D, Khoury H, et al. Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. J Clin Oncol. 1999;17:806-812.
6. Isola LM, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant. 1997;20:1033-1037.
7. Damiani D, Fanin R, Silvestri F, et al. Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood. 1997;90:36-42.
8. Weisdorf D, Miller J, Verfaillie C, et al. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF. Biol Blood Marrow Transplant. 1997;3:217-223.
9. Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood. 1996;88:89-97.
10. + cell content but is associated with delayed pancytopenia. Bone Marrow Transplant. 1998;21:431-440.
11. Vogelsang GV. Acute graft-versus-host disease following marrow transplantation. Marrow Transplant Reviews. Winter 1992/1993; 2:150.